Abstract
The consequences of macrophage depletion achieved by intravenous infusion of liposome-encapsulated clodronate (dichlormethylene diphosphonate (Cl2MDP)) on adenovirus-mediated transfer of a recombinant human α1-antitrypsin (hAAT) gene were examined in 12–14-week-old male Balb/c mice. The levels of hAAT expression following tail vein infusions of 109 p.f.u. of Ad.RSV-hAAT were approximately four-fold higher in macrophage-depleted animals than in control animals pretreated with liposome-encapsulated phosphate-buffered saline (PBS). Clodronate pretreatment also significantly increased the survival of animals injected with high doses of viral vector. Long-term studies performed in animals receiving tail vein infusions of the adenoviral vector also indicated that clodronate pretreatment significantly attenuated the rapid loss of transgene expression usually observed in immunocompetent animals. These findings indicate that the depletion of macrophages before adenovirus-mediated gene transfer may increase the transduction efficiency and reduce the rate of immunologic elimination of the adenovirally transduced cells, thereby increasing the persistence of transgene expression in immunocompetent animals.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kuzmin, A., Finegold, M. & Eisensmith, R. Macrophage depletion increases the safety, efficacy and persistence of adenovirus-mediated gene transfer in vivo. Gene Ther 4, 309–316 (1997). https://doi.org/10.1038/sj.gt.3300377
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3300377
Keywords
This article is cited by
-
SR-A and SREC-I binding peptides increase HDAd-mediated liver transduction
Gene Therapy (2014)
-
Modifications of Adenovirus Hexon Allow for Either Hepatocyte Detargeting or Targeting With Potential Evasion From Kupffer Cells
Molecular Therapy (2011)
-
The size of endothelial fenestrae in human liver sinusoids: implications for hepatocyte-directed gene transfer
Gene Therapy (2008)
-
Incorporation of a laminin-derived peptide (SIKVAV) on polymer-modified adenovirus permits tumor-specific targeting via α6-integrins
Cancer Gene Therapy (2007)
-
Gutless adenovirus: last-generation adenovirus for gene therapy
Gene Therapy (2005)